Gene · 51430
Papers1,981
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,981
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Revolutionizing cancer immunotherapy: unleashing the potential of bispecific antibodies for targeted treatment. | Front Immunol | 2023 | 38106416 | PubTator, text mining | PubMed |
| Caracterización molecular de la nueva entidad clínica relacionada con la hiperplasia suprarrenal congénita, síndrome CAH-X en población española. | Adv Lab Med | 2023 | 38075178 | PubTator, text mining | PubMed |
| Molecular characterization of the new clinical entity associated with congenital adrenal hyperplasia: the CAH-X syndrome in the Spanish population. | Adv Lab Med | 2023 | 38075167 | PubTator, text mining | PubMed |
| Estimation of Tool Life in the Milling Process-Testing Regression Models. | Sensors (Basel) | 2023 | 38067719 | PubTator, text mining | PubMed |
| Small Antibodies with Big Applications: Nanobody-Based Cancer Diagnostics and Therapeutics. | Cancers (Basel) | 2023 | 38067344 | PubTator, text mining | PubMed |
| Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2. | iScience | 2023 | 38026207 | PubTator, text mining | PubMed |
| Development and validation of a device for monitoring laryngeal motion during swallowing. | Front Robot AI | 2023 | 38023590 | PubTator, text mining | PubMed |
| The anterior perforated substance (APS) revisited: Commented anatomical and imagenological views. | Brain Behav | 2023 | 38010896 | PubTator, text mining | PubMed |
| Molecular determinants of cross-reactivity and potency by VH3-33 antibodies against the Plasmodium falciparum circumsporozoite protein. | Cell Rep | 2023 | 38007690 | PubTator, text mining | PubMed |
| Development of [89Zr]Zr-hCD103.Fab01A and [68Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET. | EJNMMI Res | 2023 | 37985555 | PubTator, text mining | PubMed |
| Novel NKG2D-directed bispecific antibodies enhance antibody-mediated killing of malignant B cells by NK cells and T cells. | Front Immunol | 2023 | 37965326 | PubTator, text mining | PubMed |
| Quantification of the Risk of Musculoskeletal Disorders of the Upper Limb Using Fuzzy Logic: A Study of Manual Wheelchair Propulsion. | Sensors (Basel) | 2023 | 37960359 | PubTator, text mining | PubMed |
| VH-CH1 switch region-inserting multispecific antibody designs and their efficacy against SARS-CoV-2 in vitro and in vivo. | Cell Discov | 2023 | 37952031 | PubTator, text mining | PubMed |
| Investigation of an international water polo tournament in Czechia as a potential source for early introduction of the SARS-CoV-2 Omicron variant into Belgium, Switzerland and Germany, November 2021. | Euro Surveill | 2023 | 37943503 | PubTator, text mining | PubMed |
| Cattle-derived knob paratopes grafted onto peripheral loops of the IgG1 Fc region enable the generation of a novel symmetric bispecific antibody format. | Front Immunol | 2023 | 37942319 | PubTator, text mining | PubMed |
| Inadequate structural constraint on Fab approach rather than paratope elicitation limits HIV-1 MPER vaccine utility. | Nat Commun | 2023 | 37940661 | PubTator, text mining | PubMed |
| Robust production of monovalent bispecific IgG antibodies through novel electrostatic steering mutations at the CH1-Cλ interface. | MAbs | 2023 | 37930310 | PubTator, text mining | PubMed |
| Fc-Engineered Therapeutic Antibodies: Recent Advances and Future Directions. | Pharmaceutics | 2023 | 37896162 | PubTator, text mining | PubMed |
| Integrative Approaches in Acute Ischemic Stroke: From Symptom Recognition to Future Innovations. | Biomedicines | 2023 | 37892991 | PubTator, text mining | PubMed |
| Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines. | Antibodies (Basel) | 2023 | 37873864 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51430/papers?page=7